ProteoNic

ProteoNic is a private biotechnology tools company providing proprietary vector technology to increase protein and viral vector production yields. Its flagship 2G UNic® platform is applicable across multiple expression systems, including CHO cells for antibodies, and is expanding into high-growth areas like cell and gene therapy manufacturing. The company generates revenue through licensing agreements and partnerships with key industry players like Abzena and Ginkgo Bioworks, positioning itself as an enabler for more efficient and cost-effective bioproduction.

2G UNic® vector technology: a modular platform of genetic elements designed to boost protein and viral vector expression yields across multiple host systems (CHO cells, yeast/fungi) and applications (stable/transient expression, lentivirus, AAV, transposon systems).

ProteoNic operates in the competitive bioproduction tools market, competing with other vector/expression technology firms (e.g., companies offering novel promoters, IRES elements, or cell line engineering services) and internal development efforts by large biopharma. Its differentiation lies in the claimed multi-fold yield increases and the 'drop-in' compatibility of its 2G UNic® platform.